http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-106466296-B
Outgoing Links
Predicate | Object |
---|---|
classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0019 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-19 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4745 |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-19 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4745 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-04 |
filingDate | 2016-04-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate | 2019-09-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationDate | 2019-09-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | CN-106466296-B |
titleOfInvention | A kind of camptothecine it is nanocrystalline and preparation method thereof |
abstract | The present invention provides nanocrystalline compositions of insoluble anti-tumor medicament camptothecin analogues and preparation method thereof.Using the alkali soluble acid of optimization it is heavy-high pressure homogenization: gradient speed acid adding after medicinal powder alkali soluble settles out nanocrystalline;Acid is heavy in two times and removes generated salt by centrifugation step;High pressure homogenization further decreases partial size.Gained camptothecin is nanocrystalline preferably with the average grain diameter of 100-150m; it is evenly distributed; only need to be added minute quantity PLURONICS F87 be freeze drying protectant can freeze-dried powder form long-term preservation, the shaking of 5% glucose solution, which is added, in when use can directly restore the state before freeze-drying.Method is easy, reproducible, is suitble to large-scale production.There is good slow release effect outside gained nanocrystal;More commercially available injection can improve the circulation time in blood plasma, improve drug organize in vivo in distribution, and have stronger antitumous effect, with wide development prospect. |
priorityDate | 2016-04-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 58.